Skincare product maker Galderma, and pharmaceutical company Sandoz both returned to their home market this week, bringing ...

NOT FOR DISTRIBUTION IN THE UNITED STATES OR IN ANY OTHER JURISDICTION IN WHICH SUCH DISTRIBUTION WOULD BE RESTRICTED BY ...

Recent refinements to a multiphase approach to delusional infestations make this treatment protocol effective even within a ...

Shareholders of Galderma Group AG are offering a 6.3% stake in the Swiss skincare group. Buyout group EQT AB, the Abu Dhabi ...

Shareholders of Galderma, the Swiss maker of skincare products including botox, launched a block trade on Monday night to ...

Investing.com -- Galderma Group AG has been downgraded by RBC Capital Markets to "sector perform" from "outperform," ...

Further to previous announcements, an affiliate of the funds known as EQT VIII ("EQT") is pleased to announce the completion of the placement of 15,000,000 shares in Galderma Group AG (SIX: GALD) (the ...

In a report released yesterday, Benjamin Jackson CFA from Jefferies maintained a Buy rating on Galderma Group AG (GALD – Research Report), with ...

The sale marks another sell-down following Galderma’s IPO last year, with the combined stake of the selling firms now below ...

Treatment-experienced patients with moderate to severe atopic dermatitis attained higher efficacy rates on rocatinlimab ...

Full Year 2024 Results Key Financial Results Revenue: US$4.44b (up 7.9% from FY 2023).